Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.05.041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Li Pang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplantation Center & Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Gua…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation, Patient Selection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Liver transplantation (LT) is an ideal therapeutic option for selected patients with hepatocellular carcinoma (HCC). The selection criteria of HCC for LT have evolved in recent decades. Downstaging therapy is a promising strategy for patients with tumor burden beyond transplant criteria to increase the chance of receiving LT and improve posttransplant survival. Downstaging therapy is also a selection tool that refines the conventional selection criteria based on tumor morphology. Recently, the success of systemic treatment, including immune checkpoint inhibitors, antiangiogenic tyrosine kinase inhibitors, and VEGF inhibitors, in advanced HCC has prompted the discussion regarding the role of systemic therapies for HCC downstaging before transplantation. In this review, we aimed to summarize the current advances in selection criteria and therapeutic options of downstaging therapy for HCC before LT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Liver Transplantation Center & Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Ge…
Zitieren
APA
Pang, L., Xu, L. B., & Wu, W. R. (2024). Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.05.041
Vancouver
Pang L, Xu LB, Wu WR. Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.05.041
BibTeX
@article{Pang2024,
author = {Pang, Li and Xu, Lei-Bo and Wu, Wen-Rui},
title = {Downstaging of Hepatocellular Carcinoma Before Liver Transplantation: Current Advances in Selection Criteria and Therapeutic Options},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.05.041}
}
EUVIMED